Effectiveness of extracorporeal shock wave therapy in patients with proximal plantar fasciitis

Changes of proximal plantar fascia microcirculation after extracorporeal shock wave therapy in patients with proximal fasciitis: a double blinded randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN49594569

Enrollment

Registered

2009-09-18

Start date

2009-09-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic plantar fasciitis Musculoskeletal Diseases Fibroblastic disorders

Interventions

Patients will be randomised by drawing cards to receive 3 or 6 sessions of radial extracorporeal shock wave therapy (ESWT) treatment (Storz Medical, Duolith SD, Switzerland), or no active treatment (c

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 60 years (either sex) 2. Suffered from proximal heel pain for more than 3 months

Exclusion criteria

Exclusion criteria: 1. Surgery in the treatment area 2. Peripheral vessel diseases 3. Diabetes mellitus 4. Peripheral neuropathy 5. Foot fracture 6. Ankle sensation loss

Design outcomes

Primary

Measure	Time frame
Microcirculation index, measured before, immediately after, at 3, 6 and 12 months after intervention	—

Secondary

Measure	Time frame
1. Plantar fascia thickness, measured before and 6 and 12 months after intervention 2. Ankle range of motion, measured before and 6 and 12 months after intervention 3. Foot Function Index, measured before, immediately after, at 3, 6 and 12 months after intervention 4. Visual Analogue Scale (VAS), measured before and 6 and 12 months after intervention	—

Countries

China

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 10, 2026